###begin article-title 0
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Differential expression of neurotrophins in postnatal C57BL/6 mice striatum
###end article-title 0
###begin p 1
Conflict of Interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th </sup>
###xml 467 469 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 479 481 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 494 496 494 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
Neurotrophin expression in early stages of development is crucial for brain assembly and function. In particular, postnatal expression of neurotrophins has not been well documented in the neostriatum and in general neurotrophins or their receptor mRNA's are normally reported, but not protein expression. In the present study, immunocytochemical expression of BDNF, NT-3 and NT-4/5 was characterized in striatal tissue of C57BL/6 mice at postnatal days 10th (P10), 21st (P21), 42nd (P42) and 80th (P80).
###end p 2
###begin p 3
###xml 452 454 452 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
We found that the expression of BDNF diminished along the postnatal time course we evaluated, while staining for NT-4 increased up to age P42 and remained constant, thereafter in the cell's soma. In contrast, NT-3 was first expressed in the neostriatal bundles and later on, in neostriatal cell somas. These results provide information about differences in the spatial and temporal expression of each neurotrophin in the neostriatum during the first 80th postnatal days.
###end p 3
###begin p 4
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF</sup>
RT-PCR procedures were also carried out to further determine whether protein levels of neurotrophins observed in the neostriatum were under control of gene expression. All neurotrophin mRNAs were expressed and only mRNABDNF was reduced during the postnatal evaluated days.
###end p 4
###begin p 5
Differences in temporal expression of neurotrophins may be related to the heterochronic development of neostriatal cell populations, but also with the specificity of each neurotrophin modulating different neuronal targets.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Neurotrophins are a family of trophic factors involved in differentiation and survival of neural cells 1. Neural Growth Factor (NGF), Brain Derived Neurotrophic Factor (BDNF), Neurotrophin 3 (NT-3) and Neurotrophin 4/5 (NT-4/5) are active in different neuronal groups throughout the embryonic period but sometimes their roles are restricted to a specific developmental stage 2.
###end p 7
###begin p 8
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 657 658 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1188 1190 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Neurotrophin distribution is not homogeneous throughout the nervous system and its expression is low during postnatal period 3. In mice striatum, neurotrophin expression is important for the establishment of neuronal connections as well as its correct cell functions. Previous studies have established messenger RNA (mRNA) expression of NGF 4, BDNF 5-7, NT-3 7, 8 and NT-4/5 9 in neostriatal tissue, although these molecules have not always been detected by Northern blot in fetal or postnatal brain 10. In addition to the presence of neurotrophin mRNA, expression of neurotrophin receptors have been documented during the early development of the striatum 3, 7, 8, 11-13. Nonetheless, the time-course of postnatal expression of neurotrophins, has not been well recognized in the striatum. Neurodegenerative disorders affecting the central nervous system are characterized by cell death of specific neuronal populations. Some degenerative diseases afflicting neural system have clear genetic origin 14; however most of them are sporadic, suggesting that other mechanisms are influencing this outcome. Striatal neurons are particularly sensitive to excitotoxicity 15 and metabolic insults 16; additionally, trophic factors can supply deficits during the first two postnatal weeks that may worsen cellular harm. As neurodegenerative diseases may be a consequence of abnormal levels of neurotrophins during the first stages of development, a clear description of their expression patterns during the two postnatal months in the normal brain is important to address before evaluating them in striatal dysfunction.
###end p 8
###begin p 9
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
We aim to describe postnatal expression of neurotrophin proteins visualized with immunostaining techniques at P10, P21, P42, and P80 in C57BL/6 mice. To further verify whether neurotrophin protein expression is determined by gene expression, we examined the mRNA levels of each neurotrophin at P10, P21 and P42 in mice striatum.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin p 11
###xml 40 42 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 681 687 <span type="species:ncbi:9913">bovine</span>
Male C57BL/6 mice (Harlan, Mexico) of 10th, 21st, 42nd, and 80th postnatal days were euthanized with pentobarbital (45mg/kg of body weight) and heart perfused with saline solution (NaCl 0.15 M) followed by phosphate-buffered saline (PBS, 0.1M, pH 7.4) with paraformaldehyde (4%). Brains were dissected and post-fixed in the same fixative for two hours at room temperature, and then transferred to a sucrose solution (30%) until they sank for cryoprotection. The brains were frozen in cold 2-methylbutane. Cryostat coronal sections (30 mum) containing dorsal striatum were cut and collected sequentially into 24-well dishes filled with blocking solution for immunocytochemistry (3% bovine serum albumin, 0.1% triton X-100 and 0.025% sodium azide in PBS).
###end p 11
###begin p 12
All animal procedures were carried out with the approval of the animal care committee of the National Autonomous University of Mexico and in agreement with the NIH.
###end p 12
###begin title 13
Immunocytochemistry (IHC)
###end title 13
###begin p 14
###xml 171 174 <span type="species:ncbi:9685">cat</span>
Tissue sections were incubated in blocking serum overnight at 4degrees C. After that, tissue slices were incubated with primary antibodies against BDNF, NT-3, and NT-4/5 (cat # AB1534SP, AB1517P, AB1519P, respectively, Chemicon International, Inc.), diluted all (1:1000) in blocking buffer and incubated for 24 hours at 4degrees C. Three washes were done with blocking solution (every 15 min), then tissue slices were incubated for 90 minutes at room temperature with the corresponding biotinylated secondary antibodies (Vector Laboratories, Burlingame, CA, USA) diluted (1:500) in blocking solution. After three washes with PB, slices were incubated with the avidin-peroxidase kit as recommended by the supplier (ABC kit; Vector). Peroxidase activity was revealed and intensified by using 3, 3'-diamobenzidine as a chromogen and nickel chloride according to the protocol provided by the supplier (Peroxidase staining kit; Vector). Finally, the staining was stopped after ~5 minutes by washing the slices with PB. For control IHC staining, the primary antibody was omitted and the tissue sections were processed with the same procedure as described before. Slices were mounted on gelatin-coated slides and cover slipped with Permount (Fisher, Inc).
###end p 14
###begin title 15
Quantitative assessment of neurotrophins expression in the striatum
###end title 15
###begin p 16
###xml 400 401 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 218 223 <span type="species:ncbi:10090">mouse</span>
Images of immunostained sections of dorsal neostriatum, from animals of 10 (n=10), 21 (n=10), 42 (n=10), 80 (n=10) days old were captured and quantified using an imaging analyses system (Image J system, NIH). For each mouse, six striatal slices (30 mum thick) spaced at intervals of 180 mum were taken and processed for immunocytochemistry. Afterwards, positive cells of four selected fields (252 mum2, area) were counted in digitized images taken at the level of dorsal striatum. Each image slice was digitized using a computer assisted system consisting of a Nikon Optiphot microscope and a digital camera connected to a Pentium computer equipped with the morphometric software analysis. Contrast and area values were kept constant and intensity threshold was established to eliminate background staining. The number of cells counted per field was averaged per animal and then per group and compared using variance analysis with a significance value of p <0.05. Post hoc Bonferroni s comparisons were done when significance was observed. Data are expressed in mean +/- S.E.M
###end p 16
###begin title 17
RNA extraction and Reverse Transcriptase (RT)-Polymerase Chain Reaction (PCR)
###end title 17
###begin p 18
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Total RNA was isolated from 0.5 g samples of frozen mice striatal tissue. The extraction was carried out with the TRIzol reagent method using the Total RNA Isolation Reagent (Invitrogen, Life Technologies, Inc.). RNA concentration was calculated from the optical density at 260 nm and the purity was determined by 260nm /280nm of absorbance 17.
###end p 18
###begin p 19
###xml 566 567 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 667 669 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 671 673 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Total RNA (~300ng) from each sample was reverse transcribed and amplified with polymerase chain reaction with gene-specific for NGF, BDNF, NT-3, NT4/5 and beta-actin, using the Super Scrit II kit (Invitrogen, Life Technologies, Inc.). Reverse Transcription was performed with a TECHNE, TC 3000 thermocycler. 2 mul of each RT product obtained was amplified with PCR using the RED Taq DNA Polymerase (Sigma-Aldrich, Inc.) in a final volume of 20 mul and 0.5 mul of each specific neurotrophin primer. The amplification cycles and the primers are specified in the Table 1. For the semi-quantitative analysis of RT-PCR products, beta-actin was used as an internal control 18, 19. Total PCR products were detected by electrophoresis on a 2% agarose gel and stained with 1 mul de SYBR Green. The area and density of PCR product bands were measured by chemio luminescence using a FUJIFILM FLA-5000 scanner and digitized with the Image Reader FLA-5000 V2.1 program. The levels of beta-actin mRNA served as an internal standard to ensure equal loading of RNA, then neurotrophin mRNA levels were normalized with the housekeeping gene. The resulting measures were expressed as arbitrary densitometry units and statistically analyzed.
###end p 19
###begin title 20
Statistical Analysis
###end title 20
###begin p 21
Data are presented as mean +/- S.E.M values if anything else is indicated. For IHC and RT-PCR experiments groups were compared using variance analysis, p <0.05 were considered to be statistically significant. Post hoc Bonferroni s comparisons were performed when significance was observed. The statistical analysis was conducted using SigmaStat statistical software for Windows, version 2.03 (Systat Software, Inc.)
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
Neurotrophin IHC expression
###end title 23
###begin p 24
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 167 168 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 337 338 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 527 528 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 569 570 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 848 850 839 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 901 904 892 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 957 959 948 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1010 1011 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
BDNF IHC expression was evaluated at 10th, 21st, 42nd, and 80th postnatal days. BDNF positive cells showed a significant reduction along the postnatal days analyzed (F3=7.907, P<0.001, Fig.1 and Fig. 4). BDNF peak expression was obtained at P10 (178 +/- 20 cells), immunostaining was present mainly in somas of ~15 mum of diameter (Fig. 1a). By P21, the number of BDNF positive cells decreased (36 +/- 14 cells) significantly (t=4.144, P<0.001, Multiple Comparison Procedures, Bonferroni s t-test) in comparison with P10 (Fig. 1b). BDNF positive cells (80 +/- 23, Fig. 1c) at P42 were significantly different than in P10 (t=2.875, P=0.032, Bonferroni s t-test). At P80, BDNF positive cells were significantly reduced (23 +/- 9) in comparison with P10 (t=4.516, P<0.001, Bonferroni s t-test). There were no differences between cells detected at P21 vs. P42 (t=1.807, P=0.449, Bonferroni s t-test); P42 vs. P80 (t=2.331, P=0.135, Bonferroni s t-test) and P21 vs. P80 (t=0.519, P=1.000, Bonferroni s t-test; Fig. 1d). There were not cells detected in control sections for IHC (data not shown).
###end p 24
###begin p 25
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 325 326 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 472 473 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 550 551 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 562 563 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
IHC expression of Neurotrophin 4/5 in the striatum evaluated at P10, P21, P42, and P80 displayed significant differences in the postnatal days evaluated (F2=4.860, P=0.011, Fig 2 and Fig. 4). We did not see any NT-4/5 IHC expression at P10 (Fig. 2 a). Nevertheless, NT-4/5 expression increased at P21 (234 +/- 30 cells, Fig. 2 b). By P42, NT-4/5 stained cells (98 +/- 21) showed a significant reduction (t=3.074, P=0.010, Bonferroni s t-test) in comparison with P21 (Fig. 2 c). No significant differences were observed at P80 (144 +/- 28 cells, Fig. 2d and Fig. 4) in comparison with P21 (t=1.874, P=0.198, Bonferroni s t-test) or P42 (t=1.329, P=0.568, Bonferroni s t-test). NT-4/5 immunostaining was mainly somatic in each evaluated age. No cells were detected in control sections for IHC were primary antibody was omitted (data not shown).
###end p 25
###begin p 26
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 283 284 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 284 286 280 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">55</sub>
###xml 339 340 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
NT-3 expression was somewhat different from the other two neurotrophins evaluated. At P10 and P21, cell staining was circumscribed to neuronal bundles (Fig. 3 a, and b). Somatic expression was observed by P42 (121.28 +/- 18) and P80 (89.6 +/- 17.5), without significant differences (t55= 1.211, P = 0.231) in the NT-3 positive cells (Fig. 3 c and d). No cells were detected in control sections for IHC where primary antibody was avoided (data not shown).
###end p 26
###begin p 27
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
A summary of neurotrophins expression in all developmental times evaluated is illustrated in Figure 4.
###end p 27
###begin title 28
Neurotrophins relative mRNA level expression
###end title 28
###begin p 29
###xml 515 516 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 629 630 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 652 656 646 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF</sup>
###xml 700 701 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 762 765 756 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 793 796 787 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 846 850 840 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-3</sup>
###xml 859 866 853 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-4/5 </sup>
###xml 918 919 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 938 939 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
It is known that neurotrophins expression is low and varies along the postnatal development; therefore to determine whether IHC staining of neurotrophins was correlated with gene expression, RT-PCR technique was carried. We examined relative mRNA levels of NGF, BDNF, NT-3 y NT-4/5, at P10, P21, and P42. beta-actin was used as a housekeeping gene and mRNA level of each neurotrophin was normalized with beta-actin endogenous expression. Neurotrophins mRNA levels were present in all postnatal ages evaluated (Fig. 5), although theirs mRNA levels varies in each age. mRNA levels of NGF did not change over the evaluated period (F2=5.119, P=0.060). mRNABDNF levels exhibited a significant reduction (F2=29.712, P<0.001) at P21 and P42 in comparison with P10 (P10 vs. P21, t=5.135, P<0.006; P10 vs. P42, t=7.547, P<0.001; Bonferroni s t-test). mRNANT-3 and mRNANT-4/5 levels did not display any significant difference (F2= 3.213, P=0.113; F2=2.289, P=0.183 respectively) at the evaluated days.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 671 673 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 677 679 677 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 683 685 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 692 694 692 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
Neurotrophins are trophic factors whose actions are crucial for differentiation, survival and the organization of neuronal connections during postnatal development. Previous studies have revealed low levels of neurotrophin mRNAs in the striatum 1-9. These earlier findings prompted us to elucidate neurotrophin protein temporal expression in normal striatal tissue, in attempts to better understand striatal abnormalities in which the lack of trophic factors during development may underlie degenerative diseases like Parkinson or Huntington diseases. In the present study we show that in mice dorsal neostriatum, temporal neurotrophin IHC expression at postnatal days 10th, 21st, 42nd and 80th is differential. We observed that when BDNF was already expressed in the neostriatum, NT-3 was expressed in the corticostriatal bundles and NT-4/5 staining was absent. With neurotrophin relative RT-PCR analysis, we observed that temporal expression of BDNF was different in comparison with NGF, NT-3 and NT-4/5.
###end p 31
###begin title 32
Temporal and spatial IHC expression of neurotrophins at the postnatal striatum
###end title 32
###begin p 33
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 341 345 341 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TrkB</sup>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Under our experimental conditions, BDNF was the only neurotrophin IHC expressed at P10 and declined with increasing postnatal age. BDNF is highly expressed during embryonic period and its expression changes during brain development 3. Our results for BDNF protein expression correlate well with the presence of its neurotrophin receptor mRNATrkB in the neostriatum, which is highly expressed during embryonic development and declines at postnatal ages 20. It has been demonstrated that neurons as well as glial cells in the striatum exhibit BDNF immunoreactivity 21 therefore, BDNF positive cells in our IHC experiments can be either type of cell.
###end p 33
###begin p 34
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
NT-3 displayed expression in striatal bundles at P10 and P21 and in striatal cells at P42, sustaining its level of ICH expression up to P80. This is the first report in mice striatal tissue documenting differences in spatial expression of NT-3 at P10 and P21, where it was circumscribed to neuronal bundles. It has been recognized that, NT-3 is anterogradely transported from the cortex similar to BDNF, consequently, NT-3 expression in the neostriatal bundles at P10 and P21 may represent anterograde transport of NT-3 from the cortex as it has been suggested to occur 22. In an earlier report, it was demonstrated that NT-3 mRNA is highly expressed in developing neurons in the cingulate cortex. That expression was transient during early stages of development and later the expression was seen in the hippocampus, supporting the notion that NT-3 promotes the development of cells that are anatomically connected 23. NT-3 influence on striatal function may be related to different neuronal populations than those affected by BDNF. Its temporal expression also suggests that, NT-3 is not necessary as a differentiation or survival factor for striatal cells. In addition NT-3 activates a different type of neurotrophin receptors, the TrkC receptors 24. Alternatively, NT-3 may influence the same population BDNF affects during another developmental time as a result of different developmental strategies and developmental speed.
###end p 34
###begin p 35
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 144 146 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
NT-4/5 is expressed in the neostriatum, when BDNF is declining (Fig. 2 and 4). NT- 4/5 should arrive to the neostriatum between postnatal day 10th and 21st, however, it is not known where the NT-4/5 is coming from, or if it is produced inside of the nucleus by neostriatal cells. Nevertheless, differences in temporal expression between BNDF and NT-4/5 are important to note, because both neurotrophins activate the same TrkB receptor 24. It is possible that the actions of both neurotrophins are not the same, or NT-4/5 actions may substitute for BDNF actions on striatal cells. Alternatively, each neurotrophin may affect distinct neuronal populations at different developmental stages. Other studies have documented that NT-4/5 is not necessary for early postnatal development of the neostriatum, still this neurotrophin is found all over the brain 25.
###end p 35
###begin p 36
###xml 74 78 <span type="species:ncbi:10090">mice</span>
The developmental differences in neurotrophins temporal expression in the mice striatum may reflect the requirements of diverse group of cells for specific trophic factors at different postnatal stages, or it may suggest that every cellular group depends upon the presence of different neurotrophins at several stages of the postnatal development.
###end p 36
###begin title 37
Neurotrophins mRNA expression in postnatal striatum
###end title 37
###begin p 38
###xml 501 502 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
To establish whether the expression of neurotrophins detected by IHC procedure was a consequence of gene expression, the mRNA levels of NGF, BDNF, NT-3, and NT-4/5, were evaluated at P10, P21 and P42. P80 was omitted from this analysis because there were no differences in neurotrophins expression between P42 and p80 in IHC experiments. Although beta-actin was used as internal standard; we included NGF as a positive control because it is recognized that NGF mRNA levels are high between P2 and P30 4.
###end p 38
###begin p 39
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGF</sup>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
mRNANGF was high and remained high at all ages evaluated as reported previously 4.This result was important to show that RNA was not degraded and PCR was working correctly.
###end p 39
###begin p 40
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 180 185 180 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF </sup>
###xml 233 237 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF</sup>
###xml 336 340 336 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF</sup>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
BDNF presence in the neostriatum has been controversial due to the lack of specific antibodies; nevertheless it has been detected by the ELISA technique 8. In our experiments, mRNABDNF levels were evaluated at P10, P21, and P45. mRNABDNF expression was low and reduced with time in agreement with our IHC results. In another study mRNA BDNF showed its maximal level by the third postnatal week (~P21) when the PCR was carried out with the RNAse protection technique 6, 7, hence discrepancies in the expression level obtained in the present study may due to differences in the experimental procedure, still our data are in consonance with those reporting that BDNF presence in the striatal tissue declines with time 3.
###end p 40
###begin p 41
###xml 116 120 116 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-3</sup>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 252 256 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-3</sup>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 448 453 448 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-3 </sup>
NT-3 expression level of its mRNA is regulated differentially in comparison to BDNF, and has been reported that mRNANT-3 levels are constant during postnatal development 7. In our experimental conditions after normalizing to the housekeeping gene, mRNANT-3 expression at P10, P21, and P42 did not exhibit any statistical change, which agrees with previous experimental reports 6, 7. In light of our IHC experiments, we believe that part of the mRNANT-3 expression comes from mRNA of corticostriatal fibers, although we can not ruled out changes due to sample processing or biological changes (see below).
###end p 41
###begin p 42
###xml 50 57 50 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-4/5 </sup>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
We did not observe significant changes in the mRNANT-4/5 level expression in the postnatal days evaluated. Although with IHC procedure there was no expression of NT- 4/5 at P10. It has been reported that NT-4/5 is expressed in low amounts by postnatal development 25 and increases in adult rodents 9, 12; therefore, differences between mRNA and IHC expression of NT-4/5 may be due to insufficient levels of mRNA for protein translation (see below).
###end p 42
###begin p 43
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 49 53 49 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF</sup>
###xml 246 252 246 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-4/5</sup>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1282 1284 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Comparing our mRNA results vs. our IHC data, mRNABDNF levels followed the same expression pattern than those obtained with IHC procedures. However, NT-3 showed high expression levels at P10 and P21 with the RT-PCR technique but not with IHC. mRNANT-4/5 expression level was also observed at P10 but not in the tissue processed with the IHC protocol. It is known that expression levels of mRNA and protein may vary in the cells, this could be due to multiple factors, e.g. low levels of protein expression, technological sensitivities, sample processing, anatomical origin of tissue and biological differences between transcript and protein abundance. A previous study showed that protein expression does not always correlate with expression levels of mRNA 26. There are several possible explanations for these discrepancies like post-transcriptional and post-translational modifications; in addition, proteins may have different half-lives 27. Gene expression analysis is more sensitive than immunocytochemical procedures; therefore it is possible that genes expressed in our study are at levels not high enough for translated protein expression detected by IHC. Satisfactory immunostaining requires preservation of protein tertiary structure in the region of the relevant epitopes 28 and it may be that some of neurotrophins antibodies are less immunoreactive than others.
###end p 43
###begin p 44
It is hoped that continued improvements in commercially available antibodies, could further elucidate the relationship between mRNA levels and corresponding protein expression. In addition to the comparison of IHC and mRNA levels by RT-PCR, there will be the need for further evaluation utilizing techniques such as in situ hybridization, western blotting, microarray and proteomic analysis, to have a better idea about neurotrophins expression through all development.
###end p 44
###begin title 45
Functional implications of neurotrophins in the postnatal striatum
###end title 45
###begin p 46
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
Changes in neurotrophic factors during postnatal development may reveal differential nourishment requirements for cell populations in the neostriatum. BDNF is transported from the cortex to the neostriatum along the corticostriatal pathway where it has a trophic effect on medium spiny neurons (MSN) 6, 29, besides its function in cell survival, BDNF induces neuronal differentiation in neurons positive to calbindin 30 and DARPP-32 31, specific markers for MSN. Actually, there is a reduction in calbindin and DARPP-32 positive neurons in BDNF knock out mice 32, 33. In addition, there is an increase in apoptotic death during development in animals that do not express TrkB receptors 32 which are those targeted by BDNF. However, its expression in postnatal and adult tissue may be linked to other functions that require low amounts of BDNF such as modulation of synaptic transmission.
###end p 46
###begin p 47
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
The presence of NT-3 in striatal tissue is not surprising, because this neurotrophin exhibits neurotrophic effects on striatal, cortical, and nigral neurons and increases the number of GABAergic and calbindin positive neurons similar to BDNF 30. This neurotrophin also promotes survival and differentiation of DARPP-32 positive neurons, increases their neurites and somatic area 33. Notably, NT-3 can be found in glial cells 34, as well as in white matter 35. In our studies, NT-3 was expressed in the neostriatal bundles at P10 and P21; we do not know if NT-3 is synthesized in glial cells, nonetheless, the presence of this neurotrophin in corticostriatal bundles suggest that, NT-3 may arrive to the striatum by anterograde transport from cortex and perhaps there is an interaction between neuronal fibers and glial cells at the neostriatum 22.
###end p 47
###begin p 48
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
NT-4/5 temporal expression at P21, P42 and P80, suggests a possible use of this neurotrophin in therapeutic manipulations because, it has been demonstrated that NT-4/5 increases the survival of GABA, calbindin and calretinin positive neurons in the neostriatum, and shares several of the BDNF neurotrophic effects because, it also acts on TrkB receptors 24, 30. Therefore, if BDNF exhibits a synthesis failure, which has been demonstrated in some degenerative illness 14, TrkB receptors might be activated with NT-4/5 to protect medium spiny neurons from cell death. Nevertheless this stimulation should be given in early phases of cellular harm, before TrkB receptors reduce their expression due to neuronal damage 36. Perhaps early stimulation with NT-4/5 will stop TrkB receptor decrement.
###end p 48
###begin p 49
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAD</sup>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
BDNF and NT-3, but not NT-4/5, regulates soma morphology in medium spiny neurons without changing GAD immunostaining or mRNAGAD expression 13. It has been demonstrated that BDNF and NT-4/5 control different functions in the same cell type, for example BDNF but not NT-4/5, increases the somatic area in neurons 37-39. According to our results (Fig. 4), BDNF and NT-4/5 may act on different neuronal populations; however, both neurotrophins may affect the same cell population at different times due to changes in their expression time course. Although both neurotrophins activate TrkB receptors, their temporal expression is different, and NT-3 activates TrkB receptors in a lower proportion and activates TrkC receptors as well 40.
###end p 49
###begin title 50
Conclusions
###end title 50
###begin p 51
As neurotrophins have important actions on neuron's survival, differentiation and maintenance, any failure in spatial and temporal neurotrophic supply may harm neostriatal cells; hence, the knowledge about their postnatal expression shall be crucial to understanding those pathologies afflicting the neostriatum early in development. In the present study, the most important result was to visualize differences in neurotrophin s temporal expression in the neostriatum. In particular, our data supporting NT-3 protein expression in fiber bundles opens the possibility of revising its function in the neostriatum as well NT-4/5 function, even though it is unclear which cells NT-4/5 is synthesized.
###end p 51
###begin p 52
Initial experiments and image acquisition of IHC procedures were performed at the laboratory of Dr. Gutierrez, (IIB, UNAM). We thank A. Vilches for his technical help in PCR experiments and to Dr. R. Villalobos (UBIMED, FES-I, UNAM) and Dr. MK Lobo (Mount Sinai University, NY) for their comments to the manuscript. This work was supported by CONACyT Grant No. 42598. V.Z. received a CONACyT fellowship.
###end p 52
###begin article-title 53
Neurotrophins: roles in neuronal development and function
###end article-title 53
###begin article-title 54
Influence of growth factors on neuronal differentiation
###end article-title 54
###begin article-title 55
###xml 96 100 <span type="species:ncbi:10116">rats</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-acelerated mice: a comparison to those of nerve growth factor and neurotrophin-3
###end article-title 55
###begin article-title 56
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Development regulation of nerve growth factor in its receptor in the rat caudate-putamen
###end article-title 56
###begin article-title 57
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain
###end article-title 57
###begin article-title 58
###xml 88 91 <span type="species:ncbi:10116">rat</span>
Differential regulation of the expresion of NGF BDNF and NT-3 after excitotoxicity in a rat model of Huntington's disease
###end article-title 58
###begin article-title 59
Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections
###end article-title 59
###begin article-title 60
Differential expression of GDNF BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion
###end article-title 60
###begin article-title 61
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues
###end article-title 61
###begin article-title 62
Mammalian neurotrophin-4 structure, chromosomal localization, tissue distribution, and receptor specificity
###end article-title 62
###begin article-title 63
###xml 60 64 <span type="species:ncbi:10116">rats</span>
Choline acetyl-transferase activity in striatum of neonatal rats increased by nerve growth factor
###end article-title 63
###begin article-title 64
Neurotrophin-5: a novel neurotrophic factor that activates trkA and trkB
###end article-title 64
###begin article-title 65
Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenative changes in striatal projection neurons after excitotoxicity in vivo
###end article-title 65
###begin article-title 66
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
###end article-title 66
###begin article-title 67
Excitotoxic injury of the neostriatum: a model for Huntington's disease
###end article-title 67
###begin article-title 68
Aging, energy, and oxidative stress in neurodegenerative diseases
###end article-title 68
###begin article-title 69
Expression of neurotrophin mRNAs in the dorsal root ganglion after spinal nerve injury
###end article-title 69
###begin article-title 70
Neurotrophins and Neurotrophin Receptors mRNAs Expression in Pancreatic Islets and Insulinoma Cell Lines
###end article-title 70
###begin article-title 71
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Expression of neurotrophin messenger RNAs during rat urinary bladder development
###end article-title 71
###begin article-title 72
Development of striatal dopaminergic function. III: Pre- and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBTK and trkC and their regulation by synaptic dopamine
###end article-title 72
###begin article-title 73
###xml 166 170 <span type="species:ncbi:10090">mice</span>
Identification of Brain -Derived Neurotrophic factor in nestin expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
###end article-title 73
###begin article-title 74
Neurotrophin trafficking by anterograde transport
###end article-title 74
###begin article-title 75
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Transient and persistent expression of NT-3/HDNF in the rat brain during postnatal development
###end article-title 75
###begin article-title 76
TrkB and TRC are differentially regulated by excitotoxicity during development of the basal ganglia
###end article-title 76
###begin article-title 77
Neurotrophin-4: the odd one out in the neurotrophin family
###end article-title 77
###begin article-title 78
###xml 50 55 <span type="species:ncbi:4932">yeast</span>
Correlation between protein and mRNA abundance in yeast
###end article-title 78
###begin article-title 79
Comparing protein abundance and mRNA expression levels on a genomic scale
###end article-title 79
###begin article-title 80
Fixation, processing, and immunochemical reagent effects on preservation of T-lymphocyte surface membrane antigens in paraffin-embedded tissue
###end article-title 80
###begin article-title 81
Anterograde transport of brain-derived neurotrophic factor and its role in the brain
###end article-title 81
###begin article-title 82
The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons
###end article-title 82
###begin article-title 83
Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons
###end article-title 83
###begin article-title 84
Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development
###end article-title 84
###begin article-title 85
Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro
###end article-title 85
###begin article-title 86
Expression of ciliary neurotrophic factor and the neurotrophins -nerve growth factor, brain-derived neurotrophic factor, and neurotrophins 3 in cultured hippocampal astrocytes
###end article-title 86
###begin article-title 87
###xml 61 64 <span type="species:ncbi:10116">rat</span>
Localization of neurotrophins-3-like immunereactivity in the rat central nervous system
###end article-title 87
###begin article-title 88
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Reduced expression of the TrKB receptor in Huntington s disease mouse models and in human brain
###end article-title 88
###begin article-title 89
Neurotrophin-4 selectively promotes survival of striatal neurons in organotypic culture
###end article-title 89
###begin article-title 90
Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo
###end article-title 90
###begin article-title 91
Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon
###end article-title 91
###begin article-title 92
The Trk family of neurotrophin receptors
###end article-title 92
###begin p 93
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BDNF immunostaining detection at the neostriatum</bold>
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</italic>
###xml 160 163 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</italic>
###xml 252 255 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c)</italic>
###xml 295 298 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(d)</italic>
BDNF immunostaining detection at the neostriatum. (a) At P10, BDNF expression was higher. The staining was restricted to the cytoplasm of small cells (~15mum). (b) Although the staining was considerably reduced by P21, it was restricted to cell somas. (c) The figure shows BDNF staining by P42. (d) At P80, there was a reduction in BDNF expression. Scale bar 160 mum.
###end p 93
###begin p 94
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-4/5 immunostaining detection at the neostriatum. </bold>
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 282 283 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
NT-4/5 immunostaining detection at the neostriatum. (a) At P10 striatal tissue did not show NT-4/5 immunostaining. (b) On P21, NT-4/5 showed its highest staining in cell bodies of ~15mum (arrows) although they can be seen in cell somas of about ~25mum as well (arrowheads). At P42 (c) and P80 (d) NT-4/5 did not change its expression between those two postnatal days, but when NT-4/5 positive cells were compared between P42 and P21, the staining was significantly different (see the text for details). Scale bar 160mum.
###end p 94
###begin p 95
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT-3 immunostaining detection at the neostriatum. </bold>
NT-3 immunostaining detection at the neostriatum. At P10 and P21 (a, b), NT-3 immunostaining was restricted to the neural bundles (arrows). At P42 (c) and P80 (d) the staining was found in the cell somas of ~15 mum (arrows) and big cells of ~25mum of diameter (arrowheads). Scale bar 160mum.
###end p 95
###begin p 96
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Number of immunostained cells for BDNF, NT-3 y NT-4/5 in the postnatal neostriatum.</bold>
###xml 134 146 134 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (white bar)</italic>
###xml 153 164 153 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(dense bar)</italic>
###xml 176 188 176 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(sparse bar)</italic>
###xml 257 258 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">55</sub>
###xml 303 304 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Number of immunostained cells for BDNF, NT-3 y NT-4/5 in the postnatal neostriatum. The bars show the number of stained cells for BDNF (white bar), NT-3 (dense bar) and NT-4/5 (sparse bar). BDNF, NT-3 and NT-4/5 staining displayed significant differences (F3=7.907, P<0.001; t55= 1.211, P = 0.231; and F2=4.860, P=0.011, respectively) in their postnatal expression. p=0.01*, p<0.001**
###end p 96
###begin p 97
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Relative RT-PCR of neurotrophins mRNA in striatal tissue from mice at P10, P21 and P42. </bold>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 356 364 <span type="species:ncbi:301928">ellipses</span>
Relative RT-PCR of neurotrophins mRNA in striatal tissue from mice at P10, P21 and P42. The upper panel shows representative PCR products of neurotrophins from 2 different mice at P10, P21, P42 stained with sybr green on a 2 % agarose electrophoresis gel. The lower panel displays data for neurotrophins mRNA from mice striatum at P10 (squares, n=3), P21 (ellipses, n=3) and P42 (triangles, n=3). Data were analyzed by measuring the area and density of the electrophoresis bands and are expressed as arbitrary densitometry units.
###end p 97
###begin p 98
Primers used for the PCR
###end p 98
###begin p 99
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Primer sequences were designed according to ref 19. All primers were obtained from Sigma-Alrdrich
###end p 99

